MoneyWorks4Me

The June 2026 quarter revenue stood at Rs. 2029.50 millions, up 11.16% as compared to Rs. 1825.70 millions during the corresponding quarter last year.Good  Net Profit growth of 40.16% reported above the corresponding previous quarter figure of Rs. 858.90 millions to Rs. 1203.80 millioins.Operating profit surged to 1572.00 millions from the corresponding previous quarter of 1186.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2029.50 1825.70 11.16 2029.50 1825.70 11.16 7383.30 7524.10 -1.87
Other Income 627.90 320.30 96.03 627.90 320.30 96.03 1953.70 1345.90 45.16
PBIDT 1572.00 1186.40 32.50 1572.00 1186.40 32.50 5331.50 4665.60 14.27
Interest 0.50 0.40 25.00 0.50 0.40 25.00 2.00 1.20 66.67
PBDT 1571.50 1186.00 32.50 1571.50 1186.00 32.50 5329.50 4664.40 14.26
Depreciation 65.60 61.40 6.84 65.60 61.40 6.84 254.30 247.70 2.66
PBT 1505.90 1124.60 33.91 1505.90 1124.60 33.91 5075.20 4416.70 14.91
TAX 302.10 265.70 13.70 302.10 265.70 13.70 1109.40 1021.80 8.57
Deferred Tax 14.50 -3.40 -526.47 14.50 -3.40 -526.47 14.50 -7.20 -301.39
PAT 1203.80 858.90 40.16 1203.80 858.90 40.16 3965.80 3394.90 16.82
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 152.00 0.00
PBIDTM(%) 77.46 64.98 19.20 77.46 64.98 19.20 72.21 62.01 16.45
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..